Treatment Response and Conditional Survival in Advanced Pancreatic Cancer Patients Treated with FOLFIRINOX: A Multicenter Cohort Study.
Fleur van der SijdeJacob L van DamBas Groot KoerkampBrigitte C M HaberkornMarjolein Y V HomsDaniëlle MathijssenMarc G H BesselinkJohanna W WilminkCasper H J van EijckPublished in: Journal of oncology (2022)
. Our study provides real-world estimates of response rates, survival, and conditional survival in patients with advanced PDAC treated with FOLFIRINOX. These results are useful for patient counseling and clinical decision making.